###begin article-title 0
###xml 18 31 18 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aristaless X </italic>
MRX87 family with Aristaless X dup24bp mutation and implication for polyAlanine expansions
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 175 203 175 203 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aristaless related homeobox </italic>
###xml 204 207 204 207 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ARX</italic>
Cognitive impairments are heterogeneous conditions, and it is estimated that 10% may be caused by a defect of mental function genes on the X chromosome. One of those genes is Aristaless related homeobox (ARX) encoding a polyA-rich homeobox transcription factor essential for cerebral patterning and its mutations cause different neurologic disorders. We reported on the clinical and genetic analysis of an Italian family with X-linked mental retardation (XLMR) and intra-familial heterogeneity, and provided insight into its molecular defect.
###end p 3
###begin title 4
Methods
###end title 4
###begin p 5
We carried out on linkage-candidate gene studies in a new MRX family (MRX87). All coding regions and exon-intron boundaries of ARX gene were analysed by direct sequencing.
###end p 5
###begin title 6
Results
###end title 6
###begin p 7
###xml 6 14 <span type="species:ncbi:9606">patients</span>
MRX87 patients had moderate to profound cognition impairment and a combination of minor congenital anomalies. The disease locus, MRX87, was mapped between DXS7104 and DXS1214, placing it in Xp22-p21 interval, a hot spot region for mental handicap. An in frame duplication of 24 bp (ARXdup24) in the second polyAlanine tract (polyA_II) in ARX was identified.
###end p 7
###begin title 8
Conclusion
###end title 8
###begin p 9
###xml 149 157 <span type="species:ncbi:9606">patients</span>
Our study underlines the role of ARXdup24 as a critical mutational site causing mental retardation linked to Xp22. Phenotypic heterogeneity of MRX87 patients represents a new observation relevant to the functional consequences of polyAlanine expansions enriching the puzzling complexity of ARXdup24-linked diseases.
###end p 9
###begin title 10
Background
###end title 10
###begin p 11
###xml 189 190 189 190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 191 192 191 192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 292 296 292 296 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FMR1</italic>
###xml 369 382 369 382 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aristaless X </italic>
###xml 383 386 383 386 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ARX</italic>
###xml 468 469 468 469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 470 471 470 471 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 458 466 <span type="species:ncbi:9606">patients</span>
X-linked mental retardation (XLMR) is a heterogeneous genetic condition characterized by variable cognitive handicap with IQ below 70. To date more than 50 XLMR genes have been recognized [1-3]. Each of them accounts for a very small proportion of the affected families with the exception of FMR1, whose loss of function mutation causes the Fragile X syndrome, and the Aristaless X (ARX) gene mutated in several syndromic and non syndromic mentally retarded patients [4-9].
###end p 11
###begin p 12
###xml 4 8 4 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ARX </italic>
###xml 189 191 189 191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 390 392 390 392 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 444 446 444 446 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 563 565 563 565 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 616 618 616 618 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 683 685 683 685 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
The ARX gene (OMIM #300382) was identified as the causative gene in several allelic brain diseases with MR such as i) XLAG or X-linked lissencephaly with abnormal genitalia (OMIM #300215) [10]; ii) Proud syndrome or mental retardation with agenesis of the corpus callosum, microcephaly, limb contractures, scoliosis, coarse faces, tapered digits and urogenital abnormalities (OMIM #30004) [10]; iii) myoclonic epilepsy syndrome (OMIM #300432) [11]; iv) West syndrome or X-linked infantile spasm syndrome with hypsarrhythmia and mental retardation (OMIM #308350) [12]; v) Partington dystonic syndrome (OMIM #309510) [13]; vi) non syndromic X-linked mental retardation (OMIM #300382) [14].
###end p 12
###begin p 13
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ARX </italic>
###xml 202 204 202 204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 225 226 225 226 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Q</italic>
###xml 226 229 226 229 <sub xmlns:xlink="http://www.w3.org/1999/xlink">50 </sub>
###xml 229 241 229 241 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Paired-like </italic>
###xml 242 250 242 250 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Prd-like</italic>
###xml 413 415 413 415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 670 672 670 672 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 673 675 673 675 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
ARX encodes the Aristaless-related protein, a bi-functional homeobox transcription factor essential for cerebral patterning and for the maintenance of specific neuronal subtypes in the cerebral cortex [15]. It belongs to the Q50 Paired-like (Prd-like) class genes, an ancient family of transcription factors with a key role in the early evolution of the animal head and development of the central nervous system [16]. The ARX protein contains a number of conserved domains, including the two DNA binding domains (Homeobox and Aristaless), and four distinct hydrophobic polyalanine tracts (polyA_I, II, III and IV) with a hypothetical role as transcriptional suppressor [17,18].
###end p 13
###begin p 14
###xml 4 8 4 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Arx </italic>
###xml 214 216 214 216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 217 219 217 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 260 264 260 264 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Arx </italic>
###xml 371 373 371 373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 374 376 374 376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 377 379 377 379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 17 22 <span type="species:ncbi:10090">mouse</span>
###xml 193 198 <span type="species:ncbi:9606">human</span>
###xml 222 228 <span type="species:ncbi:10090">Murine</span>
The Arx knockout mouse is characterized by a small brain with aberrant migration and differentiation of GABAergic interneuron progenitors and altered testes, a complex phenotype similar to the human XLAG syndrome [19,20]. Murine expression studies showed that Arx is widespread throughout telencephalic structures implicated in the pathophysiology of learning formation [13,14,20].
###end p 14
###begin p 15
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ARX </italic>
###xml 146 147 146 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 210 213 210 213 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ARX</italic>
###xml 312 314 312 314 <sub xmlns:xlink="http://www.w3.org/1999/xlink">12</sub>
###xml 404 408 404 408 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ARX </italic>
###xml 414 415 414 415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 416 417 416 417 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 650 652 650 652 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 653 655 653 655 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 685 689 685 689 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ARX </italic>
###xml 822 827 <span type="species:ncbi:9606">human</span>
ARX gene represents a hot spot for mutations in families with cognition disorders because its mutations account for 9.5% of X-linked MR families [7]. The most frequent mutation is c.428_451dup24, also known as ARXdup24, a 24 bp duplication in exon 2 resulting in elongation of the second polyalanine tract (polyA12_II), that alone might account for 6.6% of all XLMR and 41% of families with mutations in ARX gene [4-9]. The c.428_451dup24 mutation has never been found in association with severe brain malformations (i.e. XLAG or Proud syndromes). However, variable phenotypic expression is often observed within the same family with c.428_451dup24 [21,22] reinforcing the notion that ARX is a pleiotropic gene that, in a diverse genetic context and/or under the influence of modifier genes, controls different aspects of human brain morphogenesis and function.
###end p 15
###begin p 16
Here we present the molecular and clinical characterization of a new XLMR family (MRX87) linked to the Xp21 region in which we found the segregation of the c.428_451dup24 associated to intra-familial clinical variability. Our study aims to enrich the clinical and genetic description of mental defects due to polyalanine expansions in Aristaless protein.
###end p 16
###begin title 17
Methods
###end title 17
###begin title 18
Ascertainment of family members
###end title 18
###begin p 19
###xml 98 99 98 99 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 49 52 <span type="species:ncbi:9606">men</span>
###xml 636 644 <span type="species:ncbi:9606">patients</span>
Mental retardation was reported in five affected men of a four-generations Italian family (Figure 1). This family includes two affected brothers (IV:13 and IV:14), two affected first cousins (III:5 and III:10) and one affected great uncle (II:5). Peripheral venous blood samples were collected from family members. Informed consent had been obtained. Studies and procedures have been performed with the approval of the ethic committee of the host institutions according to the Helsinki Declaration. Karyotype analysis after G-banding was normal in all family members and molecular analysis of the Fragile X mutation was negative in all patients.
###end p 19
###begin p 20
###xml 92 96 92 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ARX </italic>
###xml 360 361 360 361 <sub xmlns:xlink="http://www.w3.org/1999/xlink">d</sub>
###xml 375 378 375 378 <italic xmlns:xlink="http://www.w3.org/1999/xlink">red</italic>
###xml 426 450 426 450 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Human Androgen Receptor </italic>
###xml 456 458 456 458 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AR</italic>
###xml 426 431 <span type="species:ncbi:9606">Human</span>
###xml 488 493 <span type="species:ncbi:9606">woman</span>
The four-generation family with MRX87 haplotypes for markers in Xp22-p21 and segregation of ARX mutation. Thirteen individuals from whom DNA was available were genotyped and linkage analysis was performed. Informative recombinations between the markers DXS987 and DXS207 and between DXS1061 and DXS1214 are indicated with the arrowheads. X disease haplotype (Xd) is shown in red. The X inactivation ratio, obtained by HUMARA (Human Androgen Receptor gene, AR) assay is indicated for each woman tested. The physical order of the markers analysed is, from telomere (top) to the centromere (bottom), as shown.
###end p 20
###begin title 21
Linkage analysis
###end title 21
###begin p 22
###xml 304 305 304 305 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 366 367 366 367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 693 694 693 694 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 951 955 951 955 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et a</italic>
###xml 958 960 958 960 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 797 802 <span type="species:ncbi:9606">Human</span>
###xml 882 887 <span type="species:ncbi:9606">Human</span>
Genomic DNA was isolated from the nucleated peripheral blood leukocytes using the Salting out procedure. A standard set of microsatellite markers on the X chromosome, evenly spaced every 10 cM (ABI PRISM Linkage Mapping Sets vs2, Applied Biosystems) was PCR amplified using conditions already described [3]. Thirteen individuals of the family were genotyped (Figure 1) and PCR products were analysed on automatic sequencer (ABI PRISM 3100, Applied Biosystem). Extra fluorescently labelled primers were synthesized for seven additional polymorphic markers chosen in public databases. Two-point linkage analysis was performed by the MLINK program version 5.1, from the LINKAGE software package [3]. The approved gene symbol MRX87 (Mental Retardation X-Linked 87) was assigned according to the HUGO (Human Genome Organization) nomenclature. X-inactivation status was tested by HUMARA (Human Androgen Receptor Gene) fluorescent assay according to Fimiani et al [23]. XCI patterns were classified as random (XCI </= 70%), non random (70% </= XCI </= 80%) or skewed (XCI >/= 90%).
###end p 22
###begin title 23
Mutation analysis
###end title 23
###begin p 24
###xml 60 64 60 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ARX </italic>
###xml 1045 1053 <span type="species:ncbi:9606">patients</span>
###xml 1066 1071 <span type="species:ncbi:9606">women</span>
All coding exons and the flanking intronic sequences of the ARX gene were amplified using DNA from affected and non-affected members of the MRX87 family. Eight primer pairs were used, namely: 1F 5'-CCA ACA CAC ACC CAT CCA T-3' and 1R 5'-CCG AAC ACC AAA CAT CCA A-3' for exon 1; 2aF 5'-CAA GGC GTC GAA GTC TGG TG-3' and 2aR 5'-GTA CGA CTT GCT GCG GCT GA-3', 2bF 5'-CTC CTT CAG GGT GCG GCA GC-3' and 2bR 5'-CCA GCA GCT CCT CCT CGT CG-3', 2cF 5'-CGT CAC GCA CCC GGA GGA GC-3' and 2cR 5'-AGC CCG CTG TCC CTC CCT GG-3' for exon 2; 3F 5'-TGG AGT AGG CCT GCC ATA GA-3' and 3R 5'-CCA ACC CAT CTC TCT CTC TCC-3' for exon 3; 4aF 5'-GCC AAG GGA AGG GAC GGG TA-3' and 4aR 5'-GGT AGG GGC TGA GCG GGT GG-3', 4bF 5'-GAG AAG GCA GGC GCG CAG AC-3' and 4bR 5'-ACT CCT GCC TCC TCC CTG CC-3' for exon 4; 5F 5'-CCT CGG GGA ATA TCT GGA CT-3' and 5R 5'-TTG AGT GGT GCT GAG TGA GG-3' for exon 5. The PCR fragments were sequenced in both directions with the ABI PRISM 3100 DNA sequencer (Applied Biosystem). The 24 base pair duplication in exon 2 was also visualized in patients and carrier women by separating the PCR fragments of amplicon 2a (472 bp) and 2b (409 bp) on a 3% agarose gel.
###end p 24
###begin title 25
Results
###end title 25
###begin title 26
Neurological and physical examination
###end title 26
###begin p 27
###xml 139 140 139 140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 84 92 <span type="species:ncbi:9606">patients</span>
###xml 222 230 <span type="species:ncbi:9606">patients</span>
###xml 358 361 <span type="species:ncbi:9606">men</span>
A diagnosis of MR associated with minor anomalies was made after examination of the patients (II:5, III:5, III:10, IV:13 and IV:14; Figure 1) at the Neurological Center (CARSIC, Venafro, Italy). Careful examination of the patients' phenotypes was performed and the intelligence quotient was assessed by Wechsler Adult intelligence Scale (WAIS). All affected men were born at term after normal pregnancy; no statural growth deficiency was observed. No adverse prenatal events of interest were reported and an extensive metabolic work-up yielded negative results. None of them had convulsion or hand dystonia. All had normal vision and no gonad malformations were recorded.
###end p 27
###begin p 28
###xml 295 296 295 296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 340 341 340 341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 126 134 <span type="species:ncbi:9606">Patients</span>
###xml 347 354 <span type="species:ncbi:9606">patient</span>
###xml 584 587 <span type="species:ncbi:9606">men</span>
###xml 634 637 <span type="species:ncbi:9606">man</span>
###xml 747 755 <span type="species:ncbi:9606">patients</span>
###xml 869 876 <span type="species:ncbi:9606">patient</span>
###xml 1070 1077 <span type="species:ncbi:9606">patient</span>
Four of them (II:5, III:10, IV:13 and IV:14) were thoroughly examined and a marked intra-familial heterogeneity was observed. Patients presented a variable cognitive impairment, moderate in IV:13 and IV:14 and severe in II:5, III:5, and III:10. Their clinical evaluation was summarized in Table 1. No dysmorphic signs were observed (Figure 2). In patient II:5, we found pyramidal hypotonia, bilateral Babinski signs and demential behavior. Bilateral neurosensorial deafness and a deficit of the VII cranial nerve were also observed. These signs were not present in the other affected men. However, because II:5 is the oldest affected man in the pedigree, it is possible that these symptoms are age-related and may eventually manifest in the other patients at a later time. Unlike II:5, IV:13 and IV:14, whose MRI examinations did not reveal any structural alterations, patient III:10 showed enlarged subarachnoid spaces and cerebellar tonsils below the foramen magnum (data not shown). No signs of increased intracranial pressure or cortex lesions were detected in this patient.
###end p 28
###begin p 29
###xml 23 31 <span type="species:ncbi:9606">patients</span>
Synopsis of MRX87 male patients
###end p 29
###begin p 30
OCF = Occipital Circumference; Head and neck MRA - Sag T1, axial FLAIR, axial FSE T2. Nd = not determined.
###end p 30
###begin p 31
###xml 52 56 52 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ARX </italic>
###xml 9 12 <span type="species:ncbi:9606">men</span>
###xml 114 122 <span type="species:ncbi:9606">patients</span>
Affected men of MRX87 family with c.428_451dup24 in ARX gene. No consistent facial features are present among the patients.
###end p 31
###begin p 32
###xml 119 121 119 121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 0 7 <span type="species:ncbi:9606">Patient</span>
###xml 17 24 <span type="species:ncbi:9606">patient</span>
###xml 132 139 <span type="species:ncbi:9606">patient</span>
###xml 359 362 <span type="species:ncbi:9606">men</span>
###xml 399 404 <span type="species:ncbi:9606">women</span>
Patient II:5 and patient IV:13 had severe urinary incontinence, a clinical sign often observed in association with MR [24]. Only in patient IV:14, we diagnosed a moderate intellectual handicap associated with a language deficit. Three out of four probands showed a flatfoot deformity (III:10, IV:13 and IV:14), a defect that was not evident in the unaffected men of the family. The obligate carrier women are of normal intelligence and clinically indistinguishable from their non carrier sisters. No carrier mothers recalled serious abnormalities in pregnancy.
###end p 32
###begin title 33
###xml 68 97 68 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aristaless related homeobox X</italic>
MRX87 was linked to Xp22-Xp21 and is due to a dup24 mutation in the Aristaless related homeobox X-chromosome linked gene
###end title 33
###begin p 34
###xml 245 246 245 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 257 258 257 258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 466 467 466 467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 300 307 <span type="species:ncbi:9606">patient</span>
Two-point linkage allowed mapping of the MRX87 locus to DXS987 marker in the Xp22-p21 interval. A maximum two point LOD score of 2.43 with no recombination was obtained for three adjacent markers in Xp22-Xp21.1 (DXS207, DXS8019, DXS1226; Figure 1 and Table 2). A double crossover was observed in the patient IV:13 defining the interval between the telomeric (DXS987-DXS207) and the centromeric (DXS1061-DXS1214) markers in which the disease gene was located (Figure 1).
###end p 34
###begin p 35
Two-point LOD scores analysis across the markers DXS7140 and DXS1214 linking MRX87 family to Xp22-p21 interval
###end p 35
###begin p 36
* Recombination fraction.
###end p 36
###begin p 37
###xml 25 29 25 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ARX </italic>
###xml 50 54 50 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FMR1</italic>
###xml 149 150 149 150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 151 152 151 152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 153 154 153 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 181 185 181 185 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ARX </italic>
###xml 413 416 413 416 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ARX</italic>
###xml 546 547 546 547 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 554 557 554 557 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ARX</italic>
###xml 609 613 609 613 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ARX </italic>
###xml 619 620 619 620 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 770 771 770 771 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 778 781 778 781 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ARX</italic>
###xml 1024 1027 1024 1027 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ARX</italic>
###xml 1142 1143 1142 1143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 192 200 <span type="species:ncbi:9606">patients</span>
###xml 815 823 <span type="species:ncbi:9606">patients</span>
###xml 895 898 <span type="species:ncbi:9606">men</span>
###xml 972 977 <span type="species:ncbi:9606">women</span>
This region contains the ARX gene, that is, after FMR1, the most frequently mutated gene in syndromic and non syndromic X-linked mental retardation [4,5,7]. Therefore, we sequenced ARX in the patients of MRX87 family for whom genomic DNA was available. After PCR analysis of the coding exons, the products were directly sequenced. We detected a 24-bp in frame duplication in exon 2, (c.428_451dup24 also known as ARXdup24) resulting in the duplication of nucleotides 428-451 (5'-GCCGCCGCGGC AGCCGCGGCCGCG-3'; in GenBank Accession Number ; Figure 3). The ARXdup24 is the most frequent MR mutation found in the ARX gene [7]. This duplication is an in frame expansion of the second poly-alanine tract of the ARX protein (amino acids 144-155) from 12 to 20 alanines (Figure 3). The ARXdup24 was found in all MRX87 male patients (II:5, III:5, III:10, III:13 and III:14) and was absent in the healthy men (III:4 and III:9). The obligate carriers (II:4, II:6, III:7) and at risk-women (II:3, III:6 and IV:12) were also tested. The ARXdup24 was present in all obligate carriers and in II:3, while III:6 and IV:12 did not inherit the mutation (Figure 1). Testing was also performed for individual III:2 because of her mother's status (II:3), ascertaining the absence of c.428_451dup24.
###end p 37
###begin p 38
###xml 64 68 64 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ARX </italic>
###xml 151 155 151 155 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ARX </italic>
###xml 190 193 190 193 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ARX</italic>
At the top of the figure: Electropherogram of amplicon b of the ARX exon 2 in MRX87 IV:14. The box indicates the nucleotide sequence duplicated in the ARX gene (c.428_451dup24 also known as ARXdup24). At the bottom of the figure: ARX protein functional domains and polyA tracts are shown, next to the various mutations that results in a spectrum of developmental brain phenotypes. *[10], #[13], degrees[14],  [19], section sign[27], summation operator[30], not equal[31], $[32], &[33].
###end p 38
###begin p 39
###xml 181 184 181 184 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AR </italic>
###xml 206 224 206 224 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Androgen Receptor </italic>
###xml 321 322 321 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 537 539 537 539 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 574 576 574 576 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 84 89 <span type="species:ncbi:9606">women</span>
###xml 200 205 <span type="species:ncbi:9606">human</span>
###xml 307 312 <span type="species:ncbi:9606">women</span>
X inactivation analysis (XCI) was performed in the leukocytes of four MRX87 carrier women (II:3, II:4, II:6 and III:7). We analysed the methylation status of the CpG islands of the AR gene, using the human Androgen Receptor gene fluorescent assay (HUMARA) and excluded the presence of skewed XCI in carrier women (Figure 1). This finding is not completely unexpected because most of the mutations that impair neurocognitive functioning do not confer a selective advantage in leukocytes, as in the case of individuals with Rett syndrome [25], or with Incontinentia Pigmenti [26]. Moreover, X-inactivation was measured in cells of an unaffected tissue (blood) but XCI may be different in the brain or at a critical time during brain development.
###end p 39
###begin title 40
Discussion
###end title 40
###begin p 41
###xml 88 91 88 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ARX</italic>
###xml 270 273 270 273 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ARX</italic>
###xml 475 476 475 476 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 929 930 929 930 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 1065 1069 1065 1069 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ARX </italic>
###xml 1470 1473 1470 1473 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ARX</italic>
###xml 1605 1607 1605 1607 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 1696 1698 1696 1698 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 1815 1817 1815 1817 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 1088 1096 <span type="species:ncbi:9606">patients</span>
###xml 1332 1339 <span type="species:ncbi:9606">patient</span>
###xml 1514 1517 <span type="species:ncbi:9606">boy</span>
This report describes the clinical and molecular findings of an Italian family with the ARXdup24 mutation (c.428_451dup24). We linked a new MRX condition, MRX87, to Xp22-Xp21 interval. This is one of the three hot spot regions for X-linked mental retardation containing ARX, a gene prominently mutated in both syndromic and non syndromic cognitive impairments. By sequencing its coding region in the affected MRX87 males, we identified the recurrent mutation c.428_451dup24 [7]. This is a duplication of 24 bp in exon 2 that leads to an expansion of the second polyalanine tract (polyA_II) in the ARX protein, from 12 to 20. As far as we know, there are at least 30 published families with c.428_451dup24 showing different clinical presentations including a mild MR to severe MR. Sometimes MR is observed alone, but more often, it is accompanied by a combinations of dystonia, autism, spinocerebellar ataxia, and seizures (Table 3). To this regard, the clinical evaluation of the MRX87 family contributed new elements that enrich the disease spectrum associated to ARX mutations. Indeed, patients from our family displayed novel distinctive phenotypical features with a marked clinical intra-variability and variable expression. In particular, a congenital hindbrain hernia, namely Arnold-Chiari like-malformation, was diagnosed in patient III:10. Chiari malformations are composed of a combination of brain stem and cerebellum anomalies. Among the families affected by ARXdup24, one was recently described with a boy who, apart from MR, also had a series of congenital anomalies including encephalocele [27], a neurological defect that may occur in association with Arnold-Chiari malformations [28]. Both malformations may be classified as failure of separation of neuro-ectodermal elements from the neural crest [29].
###end p 41
###begin p 42
###xml 43 46 43 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ARX</italic>
Summary of clinical data observed in other ARXdup24 families
###end p 42
###begin p 43
ND = not determined.
###end p 43
###begin p 44
###xml 4 7 4 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ARX</italic>
###xml 73 77 73 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ARX </italic>
###xml 123 127 123 127 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ARX </italic>
###xml 169 170 169 170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 173 175 173 175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 176 178 176 178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 179 181 179 181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 182 184 182 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 185 187 185 187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 188 190 188 190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 568 572 568 572 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ARX </italic>
###xml 702 711 702 711 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 779 781 779 781 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 782 784 782 784 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 793 808 <span type="species:ncbi:10090">transgenic mice</span>
###xml 938 944 <span type="species:ncbi:9606">humans</span>
The ARXdup24 underlies only a part of the complex phenotypic spectrum of ARX mutations. We can distinguish three groups of ARX mutations with different outcomes (Figure 3) [10-14,19,27,30-33]: 1. severe mutations causing severe brain patterning malformations due to alterations of the DNA binding domains (HD and Aristaless); 2. expansion in the polyA_I motif causing familial ISSX phenotypes; 3. expansion in the polyA_II motif (c.428_451dup24) causing a spectrum of XLMR conditions with huge inter- and intra-familial heterogeneity. With the exception of the severe ARX alterations classified as "loss of function", we cannot establish the functional effect of the polyA expansion mutations. Indeed, in vitro data, obtained for only the polyA_I motif, are still controversial [34,35] and no transgenic mice has been produced for each polyA mutation. On the other hand because ARX expansions in both motifs cause varying degree of MR in humans, the functions of the polyA tracts in the ARX protein could be related to the complexity of brain functions such as those controlling memory and learning.
###end p 44
###begin title 45
Conclusion
###end title 45
###begin p 46
###xml 102 105 102 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ARX</italic>
###xml 148 152 148 152 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ARX </italic>
In conclusion, the identification of a new MRX family linked to Xp22 and carrying the c.428_451dup24 (ARXdup24) underlines the high contribution of ARX to X linked mental retardation. Furthermore, the clinical findings of the affected members of the MRX87 family enhance the striking phenotypic variability associated with polyA_II expansion.
###end p 46
###begin title 47
Electronic resources
###end title 47
###begin p 48
###xml 132 134 132 134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 135 137 135 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
A number of different electronic resources were used in the research for this article. These are listed in the main reference list [36-42].
###end p 48
###begin title 49
Competing interests
###end title 49
###begin p 50
The author(s) declare that they have no competing interests.
###end p 50
###begin title 51
Authors' contributions
###end title 51
###begin p 52
###xml 309 317 <span type="species:ncbi:9606">patients</span>
###xml 376 384 <span type="species:ncbi:9606">patients</span>
CL carried out mutational analysis, X inactivation study and participated in the bioinformatic study. LS participated in the nucleotide sequence analysis and mutation identification. PD carried out statistical study. JM participated in the bioinformatic study. AM carried out clinical characterization of the patients. AD performed genotyping. VV identified and diagnosed the patients. GN participated in genetic counselling. MD participated in the design of the study. PC participated in genetic analysis. MVU participated in the design of the study and helped to draft the manuscript. MGM conceptualized, designed the study and drafted the manuscript. All authors read and approved the final manuscript.
###end p 52
###begin title 53
Pre-publication history
###end title 53
###begin p 54
The pre-publication history for this paper can be accessed here:
###end p 54
###begin p 55

###end p 55
###begin title 56
Acknowledgements
###end title 56
###begin p 57
###xml 40 48 <span type="species:ncbi:9606">patients</span>
###xml 404 411 <span type="species:ncbi:9606">patient</span>
The authors are greatly indebted to the patients and their parents for contributing blood samples and medical records. They would like to thank C. Carbone for technical assistance. Work on XLMR in our laboratories was supported by FIRB grant from MIUR-Italy. The research conducted in this study complies with current Italian laws. Written consent was obtained from their relative for publication of the patient's details and their photographs.
###end p 57
###begin article-title 58
X-linked mental retardation (XLMR): from clinical conditions to cloned genes
###end article-title 58
###begin article-title 59
X-linked mental retardation
###end article-title 59
###begin article-title 60
Mapping of MRX81 in Xp11.2-Xq12 suggests the presence of a new gene involved in nonspecific X-linked mental retardation
###end article-title 60
###begin article-title 61
Monogenic X-linked mental retardation: is it as frequent as currently estimated? The paradox of the ARX (Aristaless X) mutations
###end article-title 61
###begin article-title 62
Screening of ARX in mental retardation families: consequences for the strategy of molecular diagnosis
###end article-title 62
###begin article-title 63
Maternal mosaicism for mutations in the ARX gene in a family with X linked mental retardation
###end article-title 63
###begin article-title 64
ARX: a gene for all seasons
###end article-title 64
###begin article-title 65
The ARX mutations: a frequent cause of X-linked mental retardation
###end article-title 65
###begin article-title 66
ARX mutation c.428-451dup (24 bp) in a Brazilian family with X-linked mental retardation
###end article-title 66
###begin article-title 67
Mutations of ARX are associated with striking pleiotropy and consistent genotype-phenotype correlation
###end article-title 67
###begin article-title 68
X-linked myoclonic epilepsy with spasticity and intellectual disability: mutation in the homeobox gene ARX
###end article-title 68
###begin article-title 69
Polyalanine expansion of ARX associated with cryptogenic West syndrome
###end article-title 69
###begin article-title 70
###xml 17 22 <span type="species:ncbi:9606">human</span>
Mutations in the human ortholog of Aristaless cause X-linked mental retardation and epilepsy
###end article-title 70
###begin article-title 71
ARX, a novel Prd-class-homeobox gene highly expressed in the telencephalon, is mutated in X-linked mental retardation
###end article-title 71
###begin article-title 72
Expression of a novel aristaless related homeobox gene 'Arx' in the vertebrate telencephalon, diencephalon and floor plate
###end article-title 72
###begin article-title 73
Origin of anterior patterning. How old is our head?
###end article-title 73
###begin article-title 74
###xml 26 36 <span type="species:ncbi:7227">Drosophila</span>
Functional domains of the Drosophila Engrailed protein
###end article-title 74
###begin article-title 75
###xml 39 44 <span type="species:ncbi:9606">human</span>
Alanine tracts: the expanding story of human illness and trinucleotide repeats
###end article-title 75
###begin article-title 76
###xml 71 75 <span type="species:ncbi:10090">mice</span>
###xml 130 136 <span type="species:ncbi:9606">humans</span>
Mutation of ARX causes abnormal development of forebrain and testes in mice and X-linked lissencephaly with abnormal genitalia in humans
###end article-title 76
###begin article-title 77
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
Mouse orthologue of ARX, a gene mutated in several X-linked forms of mental retardation and epilepsy, is a marker of adult neural stem cells and forebrain GABAergic neurons
###end article-title 77
###begin article-title 78
Variable expression of mental retardation, autism, seizures, and dystonic hand movements in two families with an identical ARX gene mutation
###end article-title 78
###begin article-title 79
Screening of the ARX gene in 682 retarded
###end article-title 79
###begin article-title 80
Heterozygosity mapping by quantitative fluorescent PCR reveals an interstitial deletion in Xq26.2-q28 associated with ovarian dysfunction
###end article-title 80
###begin article-title 81
Dementia in Down's syndrome: observations from a neurology clinic
###end article-title 81
###begin article-title 82
The role of X-chromosome inactivation in the manifestation of Rett syndrome
###end article-title 82
###begin article-title 83
###xml 65 73 <span type="species:ncbi:9606">patients</span>
Molecular analysis of the genetic defect in a large cohort of IP patients and identification of novel NEMO mutations interfering with NF-kappaB activation
###end article-title 83
###begin article-title 84
###xml 18 21 <span type="species:ncbi:9606">boy</span>
ARX mutation in a boy with transsphenoidal encephalocele and hypopituitarism
###end article-title 84
###begin article-title 85
Cervical encephalocele in a newborn - Chiari III malformation. Case report and review of the literature
###end article-title 85
###begin article-title 86
Neural crest origins of the neck and shoulder
###end article-title 86
###begin article-title 87
Brain cysts associated with mutation in the Aristaless related homeobox gene, ARX
###end article-title 87
###begin article-title 88
XLMR in MRX families 29, 32, 33 and 38 results from the dup24 mutation in the ARX (Aristaless related homeobox) gene
###end article-title 88
###begin article-title 89
Three new families with X-linked mental retardation caused by the 428-451dup(24 bp) mutation in ARX
###end article-title 89
###begin article-title 90
Re-evaluation of MRX36 family after discovery of an ARX gene mutation reveals mild neurological features of Partington syndrome
###end article-title 90
###begin article-title 91
A molecular pathogenesis for transcription factor associated poly-alanine tract expansions
###end article-title 91
###begin article-title 92
A polyalanine tract expansion in Arx forms intranuclear inclusions and results in increased cell death
###end article-title 92
###begin article-title 93
Ensembl Genome DataBase
###end article-title 93
###begin article-title 94
GDB
###end article-title 94
###begin article-title 95
GenBank
###end article-title 95
###begin article-title 96
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human Genome Organization (HUGO)
###end article-title 96
###begin article-title 97
Linkage software
###end article-title 97
###begin article-title 98
OMIM
###end article-title 98
###begin article-title 99
UCSC
###end article-title 99

